{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:35:19Z","timestamp":1767850519374,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T00:00:00Z","timestamp":1227744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1472-6874-8-22","type":"journal-article","created":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T19:13:18Z","timestamp":1227813198000},"source":"Crossref","is-referenced-by-count":37,"title":["Advances in hormone replacement therapy: making the menopause manageable"],"prefix":"10.1186","volume":"8","author":[{"given":"Santiago","family":"Palacios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,27]]},"reference":[{"key":"139_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0378-5122(95)00968-X","volume":"23","author":"K Hill","year":"1996","unstructured":"Hill K: The demography of menopause. Maturitas. 1996, 23: 113-27. 10.1016\/0378-5122(95)00968-X.","journal-title":"Maturitas"},{"key":"139_CR2","volume-title":"Royal College of Physicians of Edinburgh","author":"Consensus conference on hormone replacement therapy","year":"2003","unstructured":"Consensus conference on hormone replacement therapy: Final consensus statement. Royal College of Physicians of Edinburgh. 2003"},{"key":"139_CR3","doi-asserted-by":"crossref","unstructured":"Palacios S, Calaf J, Cano A, Parrilla JJ: Spanish Menopause Society (AEEM). Relevant results of the WHI study for the management of the menopause in Spain. Maturitas. 44 (1): 83-6. 10.1016\/S0378-5122(02)00336-5. 2003 Jan 30","DOI":"10.1016\/S0378-5122(02)00336-5"},{"key":"139_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","unstructured":"Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women, principle results from the Women's Health Initiative randomized controlled trial. JAMA. 2002, 288: 321-333. 10.1001\/jama.288.3.321.","journal-title":"JAMA"},{"key":"139_CR5","doi-asserted-by":"crossref","unstructured":"Hsia J, Simon JA, Lin F, Applegate WB, Vogt MT, Hunninghake D, Carr M: Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen\/Progestin Replacement Study. Circulation. 102 (18): 2228-32. 2000 Oct 31","DOI":"10.1161\/01.CIR.102.18.2228"},{"issue":"6 Pt 1","key":"139_CR6","first-page":"589","volume":"11","author":"North American Menopause Society","year":"2004","unstructured":"North American Menopause Society: Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society. Menopause. 2004, 11 (6 Pt 1): 589-600.","journal-title":"Menopause"},{"issue":"4","key":"139_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/13697130400014615","volume":"7","author":"F Naftolin","year":"2004","unstructured":"Naftolin F, Schneider HP, Sturdee DW, Birkhauser M, Brincat MP, Gambacciani M, Genazzani AR, Limpaphayom KK, O'Neill S, Palacios S, Pines A, Siseles N, Tan D, Burger HG: Executive Committee of the International Menopause Society. Guidelines for hormone treatment of women in the menopausal transition and beyond. Cimacteric. 2004, 7 (4): 333-7. 10.1080\/13697130400014615.","journal-title":"Cimacteric"},{"key":"139_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0033-0620(95)80012-3","volume":"38","author":"F Grodstein","year":"1995","unstructured":"Grodstein F, Stampfer MJ: The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis. 1995, 38: 199-210. 10.1016\/S0033-0620(95)80012-3.","journal-title":"Prog Cardiovasc Dis"},{"key":"139_CR9","unstructured":"Gabriel SR, Carmona L, Roque M, Sanchez GL, Bonfill X: Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. CD002229-(2)"},{"key":"139_CR10","doi-asserted-by":"crossref","unstructured":"Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M, Women's Health Initiative Investigators: Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 349 (6): 523-34. 10.1056\/NEJMoa030808.","DOI":"10.1056\/NEJMoa030808"},{"key":"139_CR11","doi-asserted-by":"crossref","unstructured":"Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML: Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 297 (13): 1465-77. 10.1001\/jama.297.13.1465.","DOI":"10.1001\/jama.297.13.1465"},{"key":"139_CR12","doi-asserted-by":"crossref","unstructured":"Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB, Women's Health Initiative Investigators: Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA. 290 (13): 1729-38. 10.1001\/jama.290.13.1729.","DOI":"10.1001\/jama.290.13.1729"},{"issue":"4","key":"139_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1210\/er.2001-5002","volume":"23","author":"G Wells","year":"2002","unstructured":"Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, et al: Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev. 2002, 23 (4): 529-39. 10.1210\/er.2001-5002.","journal-title":"Endocr Rev"},{"issue":"8","key":"139_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1089\/154099903322447701","volume":"12","author":"C Crandall","year":"2003","unstructured":"Crandall C: Low dos e estrogen therapy for menopausal women: a review of efficacy and safety. J Womens Health (Larchmt). 2003, 12 (8): 723-747.","journal-title":"J Womens Health (Larchmt)"},{"issue":"6","key":"139_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12325-008-0070-6","volume":"25","author":"OE Johansen","year":"2008","unstructured":"Johansen OE, Ovisstad E: Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg\/NETA 0.1 mg. Adv Ther. 2008, 25 (6): 525-51. 10.1007\/s12325-008-0070-6.","journal-title":"Adv Ther"},{"key":"139_CR16","doi-asserted-by":"crossref","unstructured":"Maclennan AH, Broadbent JL, Lester S, Moore V: Oral oestrogen and combined oestrogen\/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004 (4): CD002978.","DOI":"10.1002\/14651858.CD002978.pub2"},{"key":"139_CR17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0029-7844(99)00643-2","volume":"95","author":"M Notelovitz","year":"2000","unstructured":"Notelovitz M, Lenihan JP, McDermott M, Kerber IJ, Nanavati N, Arce J-c: Initial 17 B-estradiol dose for treating vasomotor symptoms. Obstet Gynecol. 2000, 95: 726-31. 10.1016\/S0029-7844(99)00643-2.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"139_CR18","first-page":"293","volume":"50","author":"D de Aloysio","year":"2000","unstructured":"de Aloysio D, Rovati LC, Giamcovelli G, Setnikar 1, Bottiglioni F: Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study. Arzneimittelforschung. 2000, 50 (3): 293-300.","journal-title":"Arzneimittelforschung"},{"issue":"6","key":"139_CR19","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","volume":"75","author":"WH Utian","year":"2001","unstructured":"Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH: Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril. 2001, 75 (6): 1065-79. 10.1016\/S0015-0282(01)01791-5.","journal-title":"Fertil Steril"},{"key":"139_CR20","doi-asserted-by":"crossref","unstructured":"Palacios S, Castelo-Branco C, Cancelo MJ, Vazquez F: Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Maturitas. 50 (2): 98-10421. 10.1016\/j.maturitas.2004.04.007. 2005 Feb 14","DOI":"10.1016\/j.maturitas.2004.04.007"},{"key":"139_CR21","first-page":"987","volume":"84","author":"RA Lobo","year":"1994","unstructured":"Lobo RA, Pickar JH, Wild RA, Walsh B, Hoirvonen E: Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet Gynecol. 1994, 84: 987-95.","journal-title":"Obstet Gynecol"},{"issue":"2\u20133","key":"139_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0167-5273(02)00505-3","volume":"89","author":"G Mercuro","year":"2003","unstructured":"Mercuro G, Vitale C, Fini M, Zoncu S, Leonardo F, Rosano GM: Lipid profiles and endothelial function with low-dose hormone replacement therapy in postmenopausal women at risk for coronary artery disease: a randomized trial. Int J Cardiol. 2003, 89 (2\u20133): 257-65.","journal-title":"Int J Cardiol"},{"key":"139_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/0003-4819-106-1-40","volume":"106","author":"B Ettinger","year":"1987","unstructured":"Ettinger B, Genant HK, Cann CE: Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med. 1987, 106: 40-5.","journal-title":"Ann Intern Med"},{"key":"139_CR24","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1067\/mob.2001.117669","volume":"185","author":"M Gambacciani","year":"2001","unstructured":"Gambacciani M, Ciaponi M, Cappagli B, Genazzani AR: Effects of low-dose continuous-combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women. Am J Obstet Gynecol. 2001, 185: 1180-5. 10.1067\/mob.2001.117669.","journal-title":"Am J Obstet Gynecol"},{"key":"139_CR25","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/jbmr.5650081010","volume":"8","author":"LJ Melton III","year":"1993","unstructured":"Melton LJ, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs BL: Long-term fracture predicrion by bone mineral assessed at different skeletal sites. J Bone Miner Res. 1993, 8: 1227-33.","journal-title":"J Bone Miner Res"},{"key":"139_CR26","doi-asserted-by":"crossref","unstructured":"Gambacciani M, Cappagli B, Ciaponi M, Pepe A, Vacca F, Genazzani AR: Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women. Maturitas. 59 (1): 2-6. 10.1016\/j.maturitas.2007.10.007.","DOI":"10.1016\/j.maturitas.2007.10.007"},{"issue":"1","key":"139_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/13697130400012288","volume":"8","author":"K Peeyananjarassri","year":"2005","unstructured":"Peeyananjarassri K, Baber R: Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium and the cardiovascular system: a review of randomized clinical trials. Climacteric. 2005, 8 (1): 13-23. 10.1080\/13697130400012288.","journal-title":"Climacteric"},{"key":"139_CR28","doi-asserted-by":"crossref","unstructured":"Palacios S, Foidart JM, Genazzani AR: Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism. Maturitas. 55 (4): 297-307. 10.1016\/j.maturitas.2006.07.009.","DOI":"10.1016\/j.maturitas.2006.07.009"},{"issue":"Suppl 1","key":"139_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/09513590701585094","volume":"23","author":"T Simoncini","year":"2007","unstructured":"Simoncini T, Mannella P, Pluchino N, Genazzani AR: Comparative effects of dydrogesterone and medroxyprogesterone acetate in critical areas: the brain and the vessels. Gynecol Endocrinol. 2007, 23 (Suppl 1): 9-16. 10.1080\/09513590701585094.","journal-title":"Gynecol Endocrinol"},{"key":"139_CR30","doi-asserted-by":"crossref","unstructured":"Palacios S: Androgens and female sexual function. Maturitas. 57 (1): 61-5. 10.1016\/j.maturitas.2007.02.014.","DOI":"10.1016\/j.maturitas.2007.02.014"},{"issue":"5 Pt 1","key":"139_CR31","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/01.AOG.0000158103.27672.0d","volume":"105","author":"JE Buster","year":"2005","unstructured":"Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, Rodenberg CA, Wekselman K, Casson P: Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol. 2005, 105 (5 Pt 1): 944-52.","journal-title":"Obstet Gynecol"},{"issue":"14","key":"139_CR32","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/archinte.165.14.1582","volume":"165","author":"GD Braunstein","year":"2005","unstructured":"Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB: Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med. 2005, 165 (14): 1582-9. 10.1001\/archinte.165.14.1582.","journal-title":"Arch Intern Med"},{"issue":"9","key":"139_CR33","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.1210\/jc.2004-1747","volume":"90","author":"J Simon","year":"2005","unstructured":"Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S: Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005, 90 (9): 5226-33. 10.1210\/jc.2004-1747.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"139_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/01.gme.0000179049.08371.c7","volume":"13","author":"SR Davis","year":"2006","unstructured":"Davis SR, Mooren van der MJ, van Lunsen RH, Lopes P, Ribot C, Rees M, Moufarege A, Rodenberg C, Buch A, Purdie DW: Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause 2. 2006, 13 (3): 387-96. 10.1097\/01.gme.0000179049.08371.c7.","journal-title":"Menopause 2"},{"issue":"5","key":"139_CR35","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1097\/01.gme.0000227400.60816.52","volume":"13","author":"JL Shifren","year":"2006","unstructured":"Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C, Bearnson P, Kakos N, O'Neill S, Levine S, Wekselman K, Buch A, Rodenberg C, Kroll R: Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause. 2006, 13 (5): 770-9. 10.1097\/01.gme.0000227400.60816.52.","journal-title":"Menopause"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6874-8-22\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-8-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-8-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-8-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T20:25:26Z","timestamp":1557951926000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/1472-6874-8-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,27]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["139"],"URL":"https:\/\/doi.org\/10.1186\/1472-6874-8-22","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,27]]},"article-number":"22"}}